News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

European Medicines Evaluation Agency Reviews Roche (RHHBY)'s Avastin In Breast Cancer


9/24/2010 7:44:14 AM

ZURICH, Sept 24 (Reuters) - European healthcare regulators are reviewing the benefits of using Roche's (ROG.VX) top-selling Avastin drug in breast cancer, in the light of fresh clinical trial results.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES